SéviEye

Active

Private limited companyfounded 2014active for 12 yearsAvenue Wellington 47, 1410 Waterloo, BelgiumKBO/BCE: BE 0563.599.791

Summary

SéviEye has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36,885 and a net result of €9,093, of which €7,636 non-recurring income. Equity is shrinking by about 9% per year across the filed financial years. Its solvency ranks better than 20% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

SéviEyeActiveChecked score 90/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€175,304total assets 2025

Equity: €36,885
Profit: €9,093

Turnover not published (abbreviated or micro format)

Financial health

90 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

SEVILLA EstelleDirector

2025 accounts 2 days early2 of 5 deeds summarised

Why 90lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.26, cash €146,351Size: total assets €175,304Figures for financial year 2025 (filed 29-01-2026)Show the evidence

Checked score

Score 2025

90 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 18% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 46-19

equity 21.0% of total assets

Liquidity 57-13

short-term debt 78.6% · cash 83.5%

Profitability 47-53

return on assets 5.2%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)

Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%▼ -0.1 percentage points vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €3,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.26, compared with 1.61 in 2024, below the usual 1.5; short-term debt: 78.6% and cash: 83.5% of total assets), and 79% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 21% on solvency, 33% on liquidity, 8% on profitability and 11% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 1.26, cash €146,351

NBB · annual accounts

Size: total assets €175,304

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Figures for financial year 2025 (filed 29-01-2026)

NBB · annual accounts

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 20612 sector peers (2025).

NBB · sector comparison

Position among 20612 sector peers

Solvency

better than 20%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-01-2026, 2 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

2 days early

2024

on the day

2023

on the day

2022

on the day

2021

18 days late

2020

17 days late

2019

66 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 5 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end26-10-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

29-01-2026 Annual accounts filedfinancial year 2025 · micro…
30-06-2025 Weakest financial yearnet €9,093 ▼84.7%
31-01-2025 Annual accounts filedfinancial year 2024 · micro…

Key points

Caution: Result fell in 2025from €59,339 to €9,093 ▼ 84.7% View
Caution: Among the weakest 16% on net resultsector median €60,170 · 20,599 companies €9,093 View
Positive: 7 profitable years in a rowprofit 2025: €9,093, mostly one-off 7 years View
Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year: 2025
Total assets: €175,304
Profit: €9,093
Solvency: 21.0%

Total assets▼ 21.1%

Net result

20192025

Go to Financials

Board & ownership

Board: 1 member

SEVILLA EstelleDirector

Go to Board & ownership

Timeline

Events: 15
Since: 2016
Next accounts: by 31-01-2027

03-07-2024Appointment: SEVILLA Estelle (director)
30-06-2024Highest result from 2019 to 2025
31-01-2024Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 03-10-2014
Year ends: 30-06
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 23

Annual meeting: Second Thursday of December at 17:00
Purpose: “L'exercice de la médecine par les partenaires médicaux,en tenant compte des règles de…” (deed in French)

Go to Articles of association

Key facts about SéviEye

What is the company number of SéviEye?: 0563.599.791. In Belgium the VAT number is the company number with BE in front: BE 0563.599.791.
Where is SéviEye based?: The registered office is at Avenue Wellington 47, 1410 Waterloo.Company details
What does SéviEye do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of SéviEye?: Private limited company (BV).
When was SéviEye founded?: On 03-10-2014.
Is SéviEye still active?: Yes, SéviEye is an active enterprise in the KBO register.
What is the turnover of SéviEye?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is SéviEye profitable?: In financial year 2025, SéviEye made a profit of €9,093.
Where can I find the annual accounts of SéviEye?: SéviEye filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SéviEye due?: By 31-01-2027, for financial year 2026.Timeline